Markets:

Overview

News

Currencies

International

Treasuries

Progyny, Inc. - Common Stock (NQ:PGNY)

27.57 +0.14 (+0.49%)

Streaming Delayed Price Updated: 1:06 PM EST, Jan 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Progyny, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Akamai Technologies Issues Weak Outlook, Joins Applied Optoelectronics, JFrog And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

May 10, 2024

Via Benzinga

PGNY Stock Earnings: Progyny Beats EPS, Misses Revenue for Q1 2024 ↗

May 09, 2024

PGNY stock results show that Progyny beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 09, 2024

Via Benzinga

Progyny, Inc. Announces First Quarter 2024 Results

May 09, 2024

Early Sales Activity and New Partnerships Provide Strong Start to Selling Season, Affirming Continued Demand for Fertility and Family Building Solutions

From Progyny

Via GlobeNewswire

Why NASDAQ:PGNY Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

March 25, 2024

Is PROGYNY INC (NASDAQ:PGNY) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

Progyny: Q4 Earnings Insights ↗

February 27, 2024

Via Benzinga

Earnings Scheduled For February 27, 2024 ↗

February 27, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 07, 2024

Via Benzinga

Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report

April 25, 2024

From Progyny

Via GlobeNewswire

Progyny and RESOLVE to Honor National Infertility Awareness Week® with Events Spanning Coast to Coast

April 04, 2024

The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges

From Progyny

Via GlobeNewswire

Why NASDAQ:PGNY Is a Standout High-Growth Stock in a Consolidation Phase. ↗

February 22, 2024

PROGYNY INC (NASDAQ:PGNY), a strong growth stock, setting up for a breakout.

Via Chartmill

Why NASDAQ:PGNY Is a Standout High-Growth Stock in a Consolidation Phase. ↗

January 26, 2024

PROGYNY INC (NASDAQ:PGNY)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

Via Chartmill

Exploring the Growth Potential of NASDAQ:PGNY as It Nears a Breakout. ↗

January 04, 2024

Exploring the Growth Potential of PROGYNY INC (NASDAQ:PGNY) as It Nears a Breakout.

Via Chartmill

The 7 Most Undervalued Mid-Cap Stocks to Buy in March 2024 ↗

March 13, 2024

Wager on these top undervalued mid-cap stocks, effectively blending growth and value, with a remarkable broader-market performance in 2023.

Via InvestorPlace

Progyny, Inc. Announces Share Repurchase Program

February 29, 2024

From Progyny

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 27, 2024

Via Benzinga

Progyny, Inc. Announces Fourth Quarter 2023 Results

February 27, 2024

From Progyny

Via GlobeNewswire

NASDAQ:PGNY: a strong growth stock preparing for the next leg up?. ↗

November 14, 2023

PROGYNY INC (NASDAQ:PGNY): a strong growth stock preparing for the next leg up?.

Via Chartmill

Why the growth investor may take a look at PROGYNY INC (NASDAQ:PGNY). ↗

November 13, 2023

Exploring PROGYNY INC (NASDAQ:PGNY)'s growth characteristics.

Via Chartmill

Analyst Ratings for Progyny ↗

November 08, 2023

Via Benzinga

Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.

Via Benzinga

Alabama’s Fertility Ruling Raises Challenges for Stocks of Fertility Benefits Providers ↗

February 23, 2024

The recent Alabama State Supreme Court ruling on frozen embryos could have national repercussions. Here's what you need to know about it.

Via InvestorPlace

Progyny, Inc. Announces Details for Its Fourth Quarter and Full Year 2023 Results Report

February 13, 2024

From Progyny

Via GlobeNewswire

Affordable Care Act Enrollment Highest Since Inception: Obamacare Enrollment Witnesses 31% Jump in 2024 ↗

January 25, 2024

Historic milestone in healthcare: 21.3M Americans enroll in Obamacare, a 31% increase from last year. Act now, open enrollment persists in select states until January 31.

Via Benzinga

3 Cash-Rich Stocks to Buy for Peace of MInd in 2024 ↗

January 24, 2024

Cash-rich stocks are always good to hold for the long term. However, they’re a must in this high-interest rate environment.

Via InvestorPlace

3 Mid-Cap Stocks Poised for a Breakout in 2024 ↗

January 16, 2024

Mid-cap stocks are expected to have a breakout year especially in light of their underperformance in 2023 with these equities looking strong.

Via InvestorPlace

Progyny Expands its Leadership Team

January 11, 2024

Katie Higgins has been named Chief Commercial Officer and Steven Leist has been named Chief Technology Officer

From Progyny

Via GlobeNewswire

4 Unstoppable Multibaggers to Buy in 2024 and Hold for the Next Decade ↗

December 19, 2023

Even after posting solid results so far in 2023, these four stocks still offer long-term multibagger potential.

Via The Motley Fool

NASDAQ:PGNY—Positioned as a High-Growth Stock, Ready for a Potential Breakout. ↗

December 13, 2023

Why PROGYNY INC (NASDAQ:PGNY) Is a Promising High-Growth Stock in the Midst of Consolidation.

Via Chartmill

Progyny, Inc. Announces Third Quarter 2023 Results

November 07, 2023

From Progyny

Via GlobeNewswire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.